Shandong Weigao Group Medical Polymer Co (HKSE:01066) 3-Year EPS without NRI Growth Rate

: 13.80% (As of Jun. 2023)

View and export this data going back to 2004. Start your Free Trial

Shandong Weigao Group Medical Polymer Co's EPS without NRI for the six months ended in Jun. 2023 was HK$0.30.

During the past 12 months, Shandong Weigao Group Medical Polymer Co's average EPS without NRI Growth Rate was -19.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was 13.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 17.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Shandong Weigao Group Medical Polymer Co was 73.60% per year. The lowest was 1.00% per year. And the median was 21.40% per year.

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Shandong Weigao Group Medical Polymer Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shandong Weigao Group Medical Polymer Co 3-Year EPS without NRI Growth Rate Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Group Medical Polymer Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Shandong Weigao Group Medical Polymer Co's 3-Year EPS without NRI Growth Rate falls into.

Shandong Weigao Group Medical Polymer Co 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

Shandong Weigao Group Medical Polymer Co (HKSE:01066) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

Shandong Weigao Group Medical Polymer Co 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Shandong Weigao Group Medical Polymer Co's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Weigao Group Medical Polymer Co (HKSE:01066) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shandong Weigao Group Medical Polymer Co Ltd (HKSE:01066) » Definitions » 3-Year EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

SHWGY:USA SHWGF:USA UK2:Germany

Address

No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN

Website

https://www.weigaogroup.com

Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.

Shandong Weigao Group Medical Polymer Co (HKSE:01066) Headlines

No Headlines